Quick Answer
Sensei Biotherapeutics, Inc. reported Total Assets of $22.90 million for fiscal year 2025.
Sensei Biotherapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $22.90M | -49.5% |
| 2024 | $45.36M | -39.0% |
| 2023 | $74.37M | -37.2% |
| 2022 | $118.38M | -22.7% |
| 2021 | $153.22M | +615.1% |
| 2020 | $21.43M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $27.59M | -48.2% | -13.2% |
| June 30, 2025 | $31.78M | -46.9% | -17.0% |
| March 31, 2025 | $38.27M | -42.6% | -15.6% |
| December 31, 2024 | $45.36M | -39.0% | -14.8% |
| September 30, 2024 | $53.25M | -34.8% | -10.9% |
| June 30, 2024 | $59.80M | -33.2% | -10.3% |
| March 31, 2024 | $66.69M | -38.2% | -10.3% |
| December 31, 2023 | $74.37M | -37.2% | -8.9% |
- Sensei Biotherapeutics, Inc. showed a decrease of -49.5% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Sensei Biotherapeutics, Inc.’s total assets has grown by 6.9% (from $21.43 million to $22.90 million).
- The most recent figure is from Sensei Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: